WithdrawnPhase 2Phase 3ACTRN12619001495112

Randomised controlled trial comparing conventional steroid treatment to conventional steroids plus hyperbaric oxygen treatment in sudden sensorineural hearing loss within two weeks of onset.

The Effectiveness of Steroids and Hyperbaric oxygen for sudden sensorineural hearing loss (SHOOSH): a randomised controlled trial.


Sponsor

University of Queensland

Enrollment

100 participants

Start Date

Jan 1, 2020

Study Type

Interventional

Conditions

Summary

This trial is to determine the efficacy of HBOT in addition to steroids in the treatment of ISSHL against conventional steroids alone. There has been increasing evidence of efficacy and a recent Cochrane review suggested a large well designed RCT is needed to understand the role of HBOT. There are wide differences in clinical management across Australia due to the lack of evidence of which strategy is best. This trial hopes to bring clarity to the best management in terms of hearing outcomes.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Inclusion Criteria7

  • Documented diagnosis of ISSHL as defined by the criteria of NIDOCD.
  • Presentation within two weeks of onset of symptoms.
  • Adult aged 18 or over.
  • Normal hearing in contralateral ear.
  • Exclusion of retro-cochlear mass.
  • No contraindication to oral steroids.
  • Fitness for compression in a HBOT chamber.

Exclusion Criteria4

  • Contraindication to HBOT as assessed by a hyperbaric physician.
  • Unstable Type 1 diabetes.
  • Other causative agent for hearing loss suspected (e.g. drugs, acoustic trauma).
  • History of middle ear surgery which in the ENT surgeon’s opinion would exclude the patient from being able to be pressurized.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Hyperbaric oxygen treatment (100% oxygen via hood or face mask for 85 mins in a compressed chamber) daily at 2.4 ATA for 20 days with a 5 min air break after 20 mins at depth. Administered in accordan

Hyperbaric oxygen treatment (100% oxygen via hood or face mask for 85 mins in a compressed chamber) daily at 2.4 ATA for 20 days with a 5 min air break after 20 mins at depth. Administered in accordance with the Australian and New Zealand Standard (ASNZ 4774.2) by a qualified specialist in hyperbaric medicine. Patients have daily attendance as a hospital outpatient attendance recorded in their medical record.


Locations(6)

Prince of Wales Hospital - Randwick

NSW,QLD,TAS,WA,VIC, Australia

Fiona Stanley Hospital - Murdoch

NSW,QLD,TAS,WA,VIC, Australia

The Townsville Hospital - Douglas

NSW,QLD,TAS,WA,VIC, Australia

The Alfred - Melbourne

NSW,QLD,TAS,WA,VIC, Australia

Royal Brisbane & Womens Hospital - Herston

NSW,QLD,TAS,WA,VIC, Australia

Royal Hobart Hospital - Hobart

NSW,QLD,TAS,WA,VIC, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12619001495112